Tavlesse® (fostamatinib)

Tavlesse® is indicated for the treatment of chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments

Thromboembolic Risk in ITP

Watch

Tavlesse® (fostamatinib)
Mechanism of Action

Watch

The Evolving Role of Tavlesse® (fostamatinib)

Watch

ITP: Immune thrombocytopenia

UK-TVLS-2600022 | Date of Preparation: August 2026